Registered entities
Innovation
7 patent families (1 granted) — focus: Physics & computing, Chemistry & metallurgy; filing pace slowing. Cited 230 times.
| Year | Filings |
|---|---|
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 22.1K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Debiopharm, ING, Van Herk Groep, Global Life Science Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 18% |
| Private equity | 4 | 36% |
| Accelerator & incubator | 1 | 9% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 3 | 27% |
Hiring activity
Hires occasionally
3 roles tracked across 2 of the last 12 months
20 Feb 2026 · Patient Advocate Representative (Collector) · Irvine
6 Feb 2026 · Billing SpecialistTemporary · Irvine
19 Nov 2025 · Laboratory Support Associate I - PART TIME · Irvine
19 Sep 2025 · Customer Care Representative I · Irvine
11 Sep 2025 · Medical Science Liaison - South West · Phoenix
Based on job postings tracked across public sources.
